BioNTech SE Stock Forecast

Stock Price Forecast

According to 19 analysts polled by S&P Global, BioNTech SE stock has a consensus rating of "Buy" and an average price target of $122.69. The average 1-year stock price forecast is 41.84% higher than the current stock price, while the lowest is $75.03 (-13.26%) and the highest is $155.88 (+80.21%).

Price Target: $122.69 (+41.84%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$75.03	$122.69	$127.99	$155.88
Change	-13.26%	+41.84%	+47.97%	+80.21%

Analyst Ratings

The average analyst rating for BioNTech SE stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	15	14	13	13	13	13
Buy	1	1	1	1	1	1
Hold	4	5	5	3	5	5
Sell	0	0	0	1	0	0
Strong Sell	0	0	0	0	0	0
Total	20	20	19	18	19	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeffrey Walch Bernstein	Bernstein	Hold Maintains $96	Hold	Maintains	$96	+10.98%	Jun 5, 2026
John Newman Canaccord Genuity	Canaccord Genuity	Buy Maintains $158	Buy	Maintains	$158	+82.66%	Jun 1, 2026
Tazeen Ahmad Bank of America Securities	Bank of America Securities	Buy Maintains $130 → $125	Buy	Maintains	$130 → $125	+44.51%	Jun 1, 2026
Akash Tewari Jefferies	Jefferies	Buy Maintains $138	Buy	Maintains	$138	+59.54%	Jun 1, 2026
David Dai UBS	UBS	Buy Upgrades $117 → $135	Buy	Upgrades	$117 → $135	+56.07%	May 27, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

2.14B

from 2.87B

-25.40%

from 2.87B

Revenue Next Year

2.20B

from 2.14B

2.61%

from 2.14B

EPS This Year

-4.58

from -0.48

EPS Next Year

-4.49

from -4.58

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	18.98B	17.31B	3.82B	2.75B	2.87B	2.14B
Revenue Growth	3,834.63%	-8.78%	-77.94%	-27.96%	4.32%	-25.40%
Gross Profit	16.07B	14.32B	3.22B	2.21B	2.26B	1.66B
Gross Margin	84.66%	82.70%	84.29%	80.32%	78.70%	77.51%
Operating Income	14.85B	11.92B	971.80M	-1.29B	-1.27B	-1.51B
Net Income	10.29B	9.43B	930.30M	-665.30M	-1.14B	-1.05B
EPS	-	-	-	-	-0.48	-4.58
Free Cash Flow	-646.60M	12.01B	4.14B	-548.20M	-1.10B	-1.56B
No. Analysts	-	-	-	-	-	18

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue	2026	2027	2028
High	2.3B
Avg	2.1B
Low	2.0B

Revenue Growth

Revenue Growth	2026	2027	2028
High	-19.8%
Avg	-25.4%
Low	-30.7%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-4.58
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-